Moving from Observational Pharmacoeconomics to Interventional Pharmacoeconomics

Daniel Goldstein MD Tel Aviv University discusses Moving from Observational Pharmacoeconomics to Interventional Pharmacoeconomics at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia